The nucleus in a cell sequesters the genomic material from the cytoplasm and keeps it in a homeostatic environment. The nucleus is comparted from the cytoplasm by nuclear envelope, in which there are numerous pores that allow small molecules, such as ions, metabolites, and globular protein smaller than 40 kDa, freely passing through ([@bib16], [@bib28]). Protein over 40 kDa cannot pass through the nuclear pores unless it owns nuclear localization signal (NLS) sequence. NLS usually is rich in basic amino acids and resides near the C-terminal of the protein ([@bib16]). Through binding to nuclear import receptors including importin α and β, the NLS guides the protein transportation into the nucleus ([@bib10]).

The biosynthesis of RNA viruses occurs in the cytoplasm. The capsid proteins of RNA viruses are also distributed in the cytoplasm to assemble the progeny virions ([@bib29]). However, recent studies reveal that the capsid proteins of some RNA viruses, such as Dengue virus ([@bib4]), West Nile virus (WNV) ([@bib1], [@bib31]), and porcine reproductive and respiratory syndrome virus (PRRSV) ([@bib20]), can translocate to the nucleus and, thereafter, disturb the nuclear functions. In the cells infected with Dengue virus, a large portion of the Dengue virus capsid protein localizes in the nucleus and acts as a histone mimic to disrupt nucleosome formation ([@bib4]). The capsid protein C of WNV localizes in the nucleus through importin-mediated pathway and can be phosphorylated by protein kinase C (PKC). The phosphorylation of the WNV capsid protein C influences its nuclear trafficking by modulating the efficiency of protein C-importin-α binding ([@bib1]) and subsequently induces p53-dependent apoptosis ([@bib31]). The nucleocapsid protein N is the most abundant structural protein of PRRSV. During PRRSV infection, the N protein is specifically localized in the nucleus and nucleolus in addition to its normal cytoplasmic distribution ([@bib20]). In vivo infection with the NLS-null PRRSV mutant causes reduced viremia and increased production of neutralizing antibodies in the infected pigs. Therefore, it is evident that the nuclear localization of protein N plays a critical role in the PRRSV pathogenesis and host responses to PRRSV ([@bib20]).

Coxsakieviruses are members of *Picornaviridae* family. Group B coxsackieviruses (CVB), which include six types (CVB1--CVB6), are the major pathogens of human myocarditis and dilated cardiomyopathy ([@bib6], [@bib30]). CVB genome is a single-stranded RNA of 7.4 kb with positive polarity ([@bib14]). With only one open reading frame, CVB genome encodes a large polyprotein, which is cleaved into the mature viral proteins by viral proteinases 2A and 3C ([@bib14], [@bib21]). CVB capsid is composed of four structural proteins, VP1, VP2, VP3, and VP4. The VP1 protein, which locates on the surface of the capsid, is the main neutralizing antigen of the virus ([@bib19]). Previous studies showed that the VP1 protein not only is a structural unit of the capsid, but also involves in the viral pathogenesis. A single amino acid mutation in the VP1 protein can significantly change the plaque phenotype of CVB3 ([@bib32]). Mutations in the 5′ untranslated region and VP1-coding sequence can attenuate the cardiovirulence of CVB ([@bib2], [@bib23]). Single amino acid change (Q164K) within the exposed region of the VP1 protein can change the cytolytic and apoptotic abilities of CVB2 ([@bib11]). These findings indicate that the VP1 protein plays a critical role in the pathogenesis of CVB.

There is no report about the CVB VP1 protein translocation from the cytoplasm to the nucleus so far. In the present study, we found that the VP1 protein of CVB3 could specifically localize in the nucleus through a NLS sequence that located near its C-terminal, and the nuclear localization of CVB3 VP1 protein could deregulate the cell cycle of the VP1-expressing cells.

Results {#s0005}
=======

Fusion protein EGFP-CVB3 VP1 predominantly localizes in the nucleus {#s0010}
-------------------------------------------------------------------

HeLa cells were transfected with plasmids expressing enhanced green fluorescence protein (EGFP)-tagged CVB3 proteins VP1, VP4--VP2, 2A, 2B, 2C, 3A, 3B, 3C, and 3D, respectively. The expression of EGFP was observed at 6, 12, 24, 48, and 72 h post-transfection. Except plasmid pEGFP-2A, the others generated bright green fluorescence in the transfected cells. Surprisingly, we found that the EGFP-CVB3 VP1 (hereafter, EGFP-VP1) protein was mainly located in the nucleus, while the others were distributed in the entire cells or only in the cytoplasm ( [Fig. 1](#f0005){ref-type="fig"}). As a comparison, a plasmid expressing the EGFP-tagged VP1 protein of enterovirus 71 (EV71) was also applied to transfect HeLa cells. The EGFP-EV71 VP1 was distributed evenly in the cells ([Fig. 1](#f0005){ref-type="fig"}).Fig. 1The nuclear localization of EGFP-CVB3 VP1 protein in HeLa cells. HeLa cells were transfected with plasmids expressing the EGFP-VP1 and EGFP-3C proteins of CVB3 and the EGFP-VP1 protein of EV71, respectively. The localization of these EGFP-tagged proteins was observed at 12 h post-transfection. (A)--(D) The localization of EGFP-3C of CVB3. (D) is the enlargement of the framed part in (C). (E)--(H). The localization of EGFP-VP1 of CVB3. (H) is the enlargement of the framed part in (G). (I)--(L) The localization of the EGFP-VP1 of EV71. (L) is the enlargement of the framed part in (K). (M)--(P) The EGFP-C1 expression in the pEGFP-C1-transfected HeLa cells. (P) is the enlargement of the framed part in (O).

HeLa is a cervical cancer-originated cell line. To verify this observation, Vero cells were transfected with pEGFP-VP1. A similar result was obtained in the transfected Vero cells, in which the EGFP-VP1 protein was concentrated in the nucleus ([Fig. S1](#s0085){ref-type="sec"}, Supplementary data).

The intact CVB3 VP1 protein is also mainly localized in the nucleus {#s0015}
-------------------------------------------------------------------

The molecular weight of CVB3 VP1 protein is about 34 kDa. Theoretically, it can passively diffuse into the nucleus ([@bib26]). To check the distribution of the intact CVB3 VP1 protein, HeLa cells were transfected with pcDNA3.1-VP1, the plasmid expressing untagged CVB3 VP1. The localization of CVB3 VP1 was detected by a monoclonal antibody against enteroviral VP1. Interestingly, rather than distributing evenly in the entire cell, the untagged CVB3 VP1 was exclusively localized in the nucleus ( [Fig. 2](#f0010){ref-type="fig"}B). The localization of untagged CVB3 VP1 was identical to that of EGFP-CVB3 VP1 detected by the same assay ([Fig. 2](#f0010){ref-type="fig"}A). This observation implied that the nuclear localization of CVB3 VP1 was not a consequence of passive diffusion but active translocation.Fig. 2The nuclear localization of CVB3 VP1 protein in HeLa cells. HeLa cells were transfected with pEGFP-VP1 (A) and pcDNA3.1-VP1 (B), respectively or infected with CVB3 (MOI=1) (C). The cells transfected with the plasmids were fixed at 12 h post-transfection and detected with mouse monoclonal anti-enteroviral VP1 (clone 5-D8/1) antibody (Dako) and TRITC-labeled anti-mouse IgG antibody. One hour before the immunofluorescence detection, DAPI was added to the culture medium. The cytoplasmic and nuclear proteins in the cells infected with CVB3 viruses were extracted separately at 10 h p.i., and applied to Western blotting detection for the CVB3 VP1 protein. Histone H3 and β-actin were employed as the loading controls of nuclear and cytoplasmic proteins, respectively. (A) The localization of EGFP-VP1 protein in the HeLa cells transfected with pEGFP-VP1. (B) The localization of CVB3 VP1 protein in the HeLa cells transfected with pcDNA3.1-VP1. (C) The cytoplasmic and nuclear VP1 proteins in the CVB3-infected HeLa cells detected by Western blotting. The CVB3-infected samples collected from two parallel wells were loaded as repeats. NC: normal control.

To identify the VP1 localization in the CVB3-infected cells, the VP1 protein expressed in the HeLa cells infected with 1 multiplicity of infection (MOI) of CVB3 viruses was detected. Western blotting showed that the VP1 protein could be detected in the cytoplasm and nucleus at 10 h post-infection (p.i.) in two parallel CVB3-infected samples ([Fig. 2](#f0010){ref-type="fig"}C). These detections verified that the CVB3 VP1 protein could localize in the nuclei of the infected cells.

The nuclear localization sequence of CVB3 VP1 resides between the Met213 and Ile275 near its C-terminal {#s0020}
-------------------------------------------------------------------------------------------------------

To locate the NLS sequence of CVB3 VP1, two truncated CVB3 VP1-coding sequences with intervals of about 300 nt were generated and expressed by pEGFP-C1 ( [Fig. 3](#f0015){ref-type="fig"}A). In HeLa cells, the EGFP-tagged VP1 truncates, EGFP-VP1Δ322--843 and EGFP-VP1Δ547--843, could not localize in the nucleus ([Fig. 3](#f0015){ref-type="fig"}B). Therefore, the NLS sequence was preliminarily located in the C-terminal of CVB3 VP1 protein.Fig. 3Mapping the NLS-coding sequence of CVB3 VP1. (A) The strategy of constructing the truncated VP1-expressing plasmids. The green box represents the EGFP-coding sequence. The brown box represents the VP1 truncate that localized in the nucleus. The numbers marked in the boxes represent the nucleotide locations. The digitals after VP1Δ represent the deleted sequence. (B) The representative images of the EGFP-tagged VP1 truncates in HeLa cells. HeLa cells were transfected with the VP1 truncate-expressing plasmids. The localization of the EGFP-tagged VP1 truncates were observed at 24 h post-transfection. DAPI was added to the culture medium to stain the nuclei 1 h before the observation. The cells with the nuclear localized truncates were marked by the white arrowheads. The red arrowheads show the cells with dotted distributed truncates. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)

Four C-terminal truncates of CVB3 VP1 were further generated and expressed in HeLa cells ([Fig. 3](#f0015){ref-type="fig"}A). The truncate EGFP-VP1Δ1--546, EGFP-VP1Δ1--636, and EGFP-VP1(547--825) were all nuclear localized ([Fig. 3](#f0015){ref-type="fig"}B). Thus, the location of the NLS sequence was narrowed between Met213 and Ile275 (nt637--nt825). Since the truncate EGFP-VP1Δ1--702 did not localize in the nucleus ([Fig. 3](#f0015){ref-type="fig"}B), we concluded that the amino acids adjacent to Arg234--Ile235 (nt699--nt705) were necessary for the nuclear localization of CVB3 VP1.

Because the localization of CVB3 VP1 differed from that of EV71 VP1 in the transfected cells, the sequences between Met213 and Ile275 in the VP1 proteins of CVB3 and EV71 were compared ( [Fig. 4](#f0020){ref-type="fig"}A). The alignment showed that two basic amino acids in CVB3 VP1 protein, the 220th histidine (H) and the 230th lysine (K), were substituted by acidic threonine (T) and proline (P), respectively, in EV71 VP1. The amino acid difference in these particular sites might determine the distinct localizations of the VP1 proteins of CVB3 and EV71. Therefore, we performed site-directed mutagenesis to generate two CVB3 VP1 mutants, the VP1~H220T~ and VP1~K230P~, by substituting the His220 and Lys230 with threonine and proline, respectively, in both EGFP-tagged and untagged CVB3 VP1 proteins ([Fig. 4](#f0020){ref-type="fig"}B). In HeLa cells, the VP1~K230P~ protein with K230P mutation still localized in the nucleus, while both the untagged and EGFP-tagged VP1~H220T~ proteins with H220T mutations did not localized in the nucleus. Instead, dotted distribution of VP1~H220T~ was found in the cytoplasm ([Fig. 4](#f0020){ref-type="fig"}C and D). These data indicate that the His220 was a key amino acid residue in the NLS of CVB3 VP1 protein.Fig. 4The localizations of the CVB3 VP1 proteins with mutations in the NLS sequence. (A) The alignment of the VP1 protein sequences between Met213 and Ile275 of CVB3 (H3 strain, Genbank accession: U57056)) and EV71 (FY0805 isolate, Genbank accession: HQ882182). Two basic amino acids, His220 and Lys230 (marked in red), in CVB3 VP1 were replaced by acidic amino acids in EV71 VP1. (B) The mutations in VP1~H220T~ and VP1~K230P~. (C) The localizations of wild-type VP1, VP1~H220T~, and VP1~K230P~ proteins in the HeLa cells transfected with pcDNA3.1-VP1, pcDNA3.1-VP1H~220T~, and pcDNA3.1-VP1~K230P~. The cells were fixed and detected with monoclonal anti-enteroviral VP1 (clone 5-D8/1) antibody and TRITC-labeled anti-mouse IgG antibody at 24 h post-transfection. DAPI was added to the medium 1 h before the fixation. (D) The localizations of EGFP-VP1 and EGFP-VP1~H220T~ proteins in the HeLa cells transfected with pEGFP-VP1 and pEGFP-VP1~H220T~. The transfected cells were observed with a confocal microscope LSM 700 (Carl Zeiss) at 24 h post-transfection. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)

The region between Ala72 and Phe106 of CVB3 VP1 protein determines its dotted distribution in the cytoplasm {#s0025}
-----------------------------------------------------------------------------------------------------------

Above observations showed that the VP1~H220T~ protein was distributed in a dotted pattern in the cytoplasm. To clarify whether the dotted distribution was related to the VP1 NLS sequence, serial VP1 truncations with intervals of about 50 amino acids (150 nt) were generated and expressed with EGFP tag ( [Fig. 5](#f0025){ref-type="fig"}A). In the HeLa cells expressing these truncates, the truncate VP1Δ703--843, VP1Δ547--843, VP1Δ445--843, and VP1Δ322--843 were distributed in dotted pattern, while the truncate VP1Δ214--843 and VP1Δ118--843 were evenly distributed in the cytoplasm ([Fig. 5](#f0025){ref-type="fig"}B). These data indicate that there was a domain located in the region between the 72nd alanine to the 106th phenylalanine that determined the dotted distribution of the NLS-null CVB3 VP1 proteins.Fig. 5Mapping the dotted distribution domain of CVB3 VP1 protein. (A) Construction of the CVB3 VP1 truncates. The green boxes represent the EGFP-coding sequences. The brown box is the full-length VP1-coding sequence. The yellow boxes coded the truncated proteins that were not nuclear localized. The white boxes coded the truncated proteins that distributed evenly in the cells. (B) The representative images of the EGFP-tagged VP1 truncates expressed in HeLa cells. The cells were transfected with the truncate-expressing plasmids and observed at 24 h post-transfection. The arrowheads show the cells with the dotted distributed EGFP-VP1 truncates. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)

CVB3 VP1 nuclear localization induces cell cycle deregulation {#s0030}
-------------------------------------------------------------

To evaluate the impact of CVB3 VP1 nuclear localization on the cells, HeLa cells were transfected with pEGFP-VP1 and pEGFP-VP1~H220T~, and the cell cycle, NF-κB expression, and apoptosis in the treated cells were detected by flow cytometry and Western blotting. We did not observed a significant alteration in the expression of NF-κB p65 and cleaved poly(ADP-ribose) polymerase 1 (PARP1) (data not shown). However, the cell cycle in the EGFP-VP1-expressing cells without synchronization treatment was altered significantly from that of the EGFP-VP1~H220T~-expressing cells at the time point of 48 h post-transfection. Compared to the cell cycle in the normal control group (25.5±1.3% for S phase and 8.0±2.4% for G2-M phase) at 48 h post-transfection, the EGFP-VP1-expressing cells showed prolonged S phase (44.2±0.5%) and shortened G2-M phases (2.5±3.6%), while the EGFP-VP1~H220T~-expressing cells showed prolonged S phase in less extent (34.1±4.2%) and relatively normal G2-M phases (6.5±2.2%) ( [Fig. 6](#f0030){ref-type="fig"}). There was no significant change among the cell cycles of three groups at 24 h post-transfection, possibly due to the plasmids needed time for gene expression. A similar prolonged S phase was also observed in the synchronized EGFP-VP1-expressing cells at 48 h post-transfection ([Fig. S4](#s0085){ref-type="sec"}, Supplementary data). These data suggest that the event of CVB3 VP1 nuclear localization alone could sufficiently deregulate the cell cycle.Fig. 6The cell cycle of the HeLa cells expressing CVB3 VP1 proteins. HeLa cells were transfected with pEGFP-VP1 and pEGFP-VP1~H220T~, respectively. The cells were harvested at 24 and 48 h post-transfection and dyed with PI reagents. About 20,000 cells were counted for cell cycle by a flow cytometer FACSCalibur (mean±standard deviation, *n*=3). NC: normal control.

Discussion {#s0035}
==========

The capsid protein of picornavirus, which functions as the structural unit of the viral particle, is usually localized in the cytoplasm ([@bib29]). Recent studies demonstrated that the capsid proteins of some RNA viruses, e.g., Dengue virus ([@bib4]), West Nile virus ([@bib1], [@bib31]), coronavirus ([@bib22]), and PRRSV ([@bib20]), can localize in the nucleus, and thereafter, interfere with the host cellular phenotypes including the disruption of nucleosome formation ([@bib4]), cell cycle ([@bib3]), and apoptosis ([@bib31]). These studies suggest that, except determining the viral tropism, the capsid proteins can directly interact with the nucleus and play roles in the pathogenesis of diseases caused by these viruses.

So far, there is no report about the nuclear localization of coxsackievirus capsid protein. In this study, we found that CVB3 VP1 protein, mediated by a NLS sequence near its C-terminal, was actively localized in the nucleus. Moreover, the cell cycle was disrupted in the VP1-expressing cells. Our findings suggest that there may be a direct interaction between the VP1 capsid protein of CVB3 and the cellular nuclear proteins, and this interaction may contribute to the pathogenesis of CVB3.

Our data demonstrate that both the EGFP-tagged and untagged VP1 proteins were predominantly localized in the nuclei of the HeLa cells ([Fig. 1](#f0005){ref-type="fig"}, [Fig. 2](#f0010){ref-type="fig"}). The EGFP-VP1 expression in Vero cells verified the observation in HeLa cells ([Fig. S1](#s0085){ref-type="sec"}). The VP1 protein nuclear localization was further confirmed by Western blotting in the cells infected with CVB3 viruses ([Fig. 2](#f0010){ref-type="fig"}). These results indicate that the VP1 nuclear localization is an intrinsic procedure in the life cycle of CVB3.

CVB3 VP1 protein is approximately 34 kDa in molecular weight. Theoretically it can freely pass through the nuclear pore as long as it is globular. However, the EGFP-VP1 protein is about 60 kDa, that is beyond the 40 kDa limit of passive diffusion through the nuclear pores for a globular protein. On the other hand, previous study showed that the conformation of CVB3 VP1 was not globular when it assembled the capsid with VP2, VP3, and VP4 ([@bib17], [@bib18]). Therefore, we speculated that CVB3 VP1 protein might own a NLS sequence that helped the EGFP-VP1 protein passing through the nuclear pore. To locate the NLS sequence in the CVB3 VP1 protein, truncation strategy was employed in this study. By expressing two VP1 truncates at about 100-amino acid intervals, the NLS sequence was roughly located near the C-terminal of VP1 protein. Further truncations narrowed the NLS sequence in the region between Met213 and Ile275 ([Fig. 3](#f0015){ref-type="fig"}).

Although the picornaviral genomes share great similarity in terms of structure and sequence ([@bib25]), the localization of EV71 VP1 protein was apparently different from that of CVB3 VP1 protein in HeLa cells ([Fig. 1](#f0005){ref-type="fig"}). The localization difference between the VP1 proteins of CVB3 and EV71 provided a shortcut for predicting the NLS sequence of CVB3 VP1. NLS is usually a basic amino acid-rich sequence ([@bib16], [@bib26]). The alignment for the Met213--Ile275 sequences showed that two basic amino acids (His220 and Lys230) in CVB3 VP1 were substituted by acidic amino acid threonine and proline, respectively, in EV71 VP1 ([Fig. 4](#f0020){ref-type="fig"}A). By expressing the mutants VP1~H220T~ and VP1~K230P~ in HeLa cells, we found that the VP1~H220T~ mutant completely abolished the nuclear translocation ([Fig. 4](#f0020){ref-type="fig"}). The result indicates that the His220 is one of the determinative amino acids in the NLS of CVB3 VP1 protein.

By comparing the sequence around His220 with the reported NLS sequences ([@bib16]), no typical NLS sequence was identified in CVB3 VP1 protein. Furthermore, the VP1Δ1--702 and VP1Δ703--843 truncates were not nuclear localized ([Fig. 3](#f0015){ref-type="fig"}, [Fig. 5](#f0025){ref-type="fig"}). These observations suggest that the NLS sequence of CVB3 VP1 protein might span a wide region ( [Fig. 7](#f0035){ref-type="fig"}). Alignment of the Met213--Ile275 sequences in the VP1 proteins of CVB1 to CVB6 showed that this region was highly conserved ([Fig. 7](#f0035){ref-type="fig"}). It is possible that the VP1 proteins of all CVB types may also have the potential of nuclear localization.Fig. 7Diagram of the NLS sequence of CVB3 VP1. (A) The Locations of the NLS sequence in CVB3 VP1. Dark box: the region where the NLS sequence was located. Grey box: this part caused the dotted distribution of CVB3 VP1. "aa" stands for amino acid. (B) The alignment of the VP1 sequences between Met213 and ILe275 of the six CVB types. The His220 and Lys230 are marked with the dark and white arrowheads, respectively. The grey arrowhead shows the bound of VP1Δ1--702 and VP1Δ702--843.

Another interesting finding in this study is that the full-length mutant VP1~H220T~ and some wild-type VP1 truncates distributed in a dotted pattern rather than evenly distributed in the cytoplasm. Using truncation strategy, we found that the dotted distribution was dependent on a domain located between Ala72 and Phe106 ([Fig. 5](#f0025){ref-type="fig"}, [Fig. 7](#f0035){ref-type="fig"}). It seems that this is a membrane-binding domain that keeps the truncated VP1 proteins binding to the cytoplasmic membrane structures. Further study is needed to elucidate this molecular event.

We noticed that there was abundant cytoplasmic VP1 protein in the cells infected with CVB3 ([Fig. 2](#f0010){ref-type="fig"}C). A part of the cytoplasmic VP1 should be that assembled in the progeny virus capsid. It might also be a result of the relocation of nuclear localized VP1 somehow caused by CVB3 infection. Previous studies demonstrated that enteroviral protease 2A could cause the cytoplasmic redistribution of nuclear proteins through cleaving the nuclear pore complex (NPC) components ([@bib13], [@bib12]). Indeed, considerable amount of cytoplasmic EGFP-VP1 could also be observed in the pEGFP-VP1-transfected cells with CVB3 infection simultaneously ([Fig. S3](#s0085){ref-type="sec"}, Supplementary data).

The nuclear trafficking of viral capsid proteins can disrupt the host cellular phenotypes ([@bib1], [@bib3], [@bib4], [@bib16], [@bib31]). The host chromatin and histone proteins are always the targets of the viral capsid proteins ([@bib1], [@bib4], [@bib22], [@bib31], [@bib33]). Dengue virus capsid protein can act as a histone mimic to disrupt the nucleosome formation ([@bib4]). WNV capsid protein C can bind to human double minute 2 (HDM2) and induce p53-dependent apoptosis ([@bib1]). Influenza virus matrix protein M1 can interact with the core histones ([@bib33]). The nucleocapsid protein N of severe acute respiratory syndrome coronavirus arrest the cells in S phase by directly inhibiting the cyclin-CDK complex ([@bib22]). To evaluate whether the CVB3 VP1 nuclear localization affects cellular phenotype, the cell cycle of the HeLa cells expressing CVB3 VP1 and VP1~H220T~ proteins was preliminarily analyzed. Our results demonstrate that the VP1 nuclear localization caused a prolonged S phase and shortened G2-M phase in the asynchronous cells ([Fig. 6](#f0030){ref-type="fig"}) and a prolonged S phase only in the synchronized cells ([Fig. S4](#s0085){ref-type="sec"}, Supplementary data). These data imply that the VP1 nuclear localization may somehow interfere with cellular genome replication or disrupt cell cycle regulators, e.g., cyclin A, CDK2, and retinoblastoma protein ([@bib5]). The precise mechanism needs further study.

Previous studies ([@bib7], [@bib8], [@bib9]) showed that CVB3 replication is influenced by host cell cycle status. The protein synthesis and viral production of CVB3 are dramatically higher in HeLa cells arrested at the G1 or G1/S stage, while the virus-infected cells at the G0 or G2-M stage express less protein and make less infectious CVB3. In addition, CVB3 infection can also disrupt host cell homeostasis by inducing cell cycle arrest through increasing ubiquitin-dependent proteolysis of cyclin D1 ([@bib15]). Therefore, the shortened G2-M phase induced by the VP1 nuclear localization may facilitate the biosynthesis of CVB3.

However, it should be emphasized that this was only a preliminary survey of the biological impact of the CVB3 VP1 nuclear localization. The overexpression strategy may not properly represent the natural scenario of CVB3 infection in cells. Therefore, more extensive studies are needed to well interpret this molecular event in CVB3 infection.

Taken together, CVB3 VP1 protein owns nuclear localization sequence near its C-terminal and can actively translocate from the cytoplasm into the nucleus. The nuclear localization of CVB3 VP1 protein can disrupt the cell cycle, and may be one of the pathogenic mechanisms of CVB3.

Materials and methods {#s0040}
=====================

Cell lines and viruses {#s0045}
----------------------

HeLa and Vero cells were cultured in Dulbecco Modified Eagle Medium (DMEM) (Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum (FBS) (Biological Industries, Kibbutz Beit Haemek, Israel) and antibiotics (50 U/ml penicillin and 0.1 mg/ml streptomycin) at 37 °C with 5% CO~2~. CVB3 H3 strain was passaged in HeLa cells and titered by plaque assay as described previously ([@bib27], [@bib34]).

Plasmid constructions {#s0050}
---------------------

A pcDNA3.1-based, EGFP-expressing plasmid, designated as pEGFP-C1 ([@bib27]), was used for expressing the full-length and truncated CVB3 VP1 proteins. The coding sequence of CVB3 VP1 was obtained by polymerase chain reaction (PCR) from pMKS1, a plasmid carries the full-length cDNA of CVB3 H3 genome ([@bib7]). Plasmid pEGFP-VP1 was constructed by inserting the CVB3 VP1-coding sequence, which contained 843 nucleotides (nt) and coded 281 amino acids (aa), to the *Hind* III-*Xba* I site at the 3′ end of the EGFP-coding sequence in pEGFP-C1. A series of truncated CVB3 VP1 sequences were generated from the pEGFP-VP1 by PCR assay ([Fig. 3](#f0015){ref-type="fig"}, [Fig. 5](#f0025){ref-type="fig"}). The PCR products were purified by 1% agarose gel electrophoresis and the Gel Extraction Kit WD412 (Huashun Biotech, Shanghai, China). The purified PCR products were digested with *Hind* III and *Xba* I (TaKaRa, Dalian, China), and ligated to the pEGFP-C1 that has been digested with the same restriction enzymes. All plasmids were confirmed by sequencing (Invitrogen Beijing, Beijing, China). The primers used in these constructions were listed in [Table 1](#s0080) (Supplementary data).

Site-directed mutagenesis {#s0055}
-------------------------

The amino acid alignment for the Met213--Ile275 peptides in the VP1 proteins of CVB3 (Genbank accession: U57056) and EV71 (Genbank accession: HQ882182) showed that two basic amino acids, His220 and Lys230, in the CVB3 VP1 were replaced by acidic amino acids, threonine (T) and proline (P), in the EV71 VP1, respectively. Therefore, two mutants of CVB3 VP1, VP1~H220T~ and VP1~K230P~, were generated in this study by overlapping PCR strategy as described previously ([@bib27]). Briefly, for generating VP1~H220T~, the pEGFP-VP1 DNA was amplified with VP1 sense primer and H220T antisense primer, and with H220T sense primer and VP1 antisense primer ([Table 1](#s0080), Supplementary data), respectively. The PCR productions mixed and amplified with VP1 sense and antisense primers together. The resultant DNA was digested with *Hind* III and *Xba* I and cloned into pEGFP-C1. VP1~K230P~ was generated as the same protocol except using the K230P primers ([Table 1](#s0080), Supplementary data).

Transfection and fluorescence observation {#s0060}
-----------------------------------------

Approximately 70% confluent HeLa cells were transfected with various plasmids by Lipofectamine 2000 (Invitrogen, Carlsbad, CA) as described previously ([@bib24]). The EGFP expression in the transfected cells with various plasmids were observed with a microscope Axiovert 200 (Carl Zeiss, Gottingen, Germany) or a confocal microscope LSM 700 (Carl Zeiss MicroImaging, Jana, Germany). DAPI was added to the culture 1 h before the microscopy examination for staining the nuclei.

Immunofluorescence assay {#s0065}
------------------------

HeLa cells grown in a 24-well plate were washed with precooling phosphate buffered saline (PBS) for 2 times and fixed with freshly prepared 4% formaldehyde for 15 min. The fixed cells were permeabilized with 0.1% Triton X-100 in PBS for 10 min and blocked with 1% bovine serum albumin (BSA) for 20 min. The blocked cells were incubated with 1:500 diluted monoclonal mouse anti-enteroviral VP1 (clone 5-D8/1) antibody (Dako, Glostrup, Denmark) at 4 °C overnight. After washing in PBS for 5 min×3 times, the cells were incubated with 1:1000 diluted TRITC-labeled goat anti-mouse IgG antibody (Zhongshan Jinqiao Biotech, Beijing, China). The cells were dyed with 0.1 μg/ml DAPI and observed with Axiovert 200.

Western blot {#s0070}
------------

The cytoplasmic and nuclear proteins of the CVB3-infected HeLa cells were separately extracted 10 h p.i. with the Protein Extraction Kit P0028 (Beyotime Biotech, Beijing, China), and quantitated with Bradford reagents (Bio-Rad, Hercules, CA). The protein extracts (2 μg/lane) were separated by 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The separated proteins were transferred to a polyvinylidene fluoride (PVDF) membrane (0.22 μm, Millipore, Billerica, MA). The membrane was blocked with 5% nonfat milk for 2 h at 37 °C, and overnight incubated at 4 °C with antibodies against enterovirus VP1 (Dako), histone H3 (Abcam, Cambridge, MA), and β-actin (Santa Cruz Biotechnology, Santa Cruz, CA), respectively. The membrane was routinely washed and then incubated with a horseradish peroxidase-conjugated anti-IgG antibody (Zhongshan Goldenbridge Biotech) at a dilution of 1:4000 for 2 h at 37 °C. The membrane was stained with the SuperSignal kit (Pierce, Rockford, IL) and imaged by a charge-coupled camera LAS4000 (Fujifilm, Tokyo, Japan). Histone H3 and β-actin were employed as loading controls for the nuclear and cytoplasmic proteins, respectively.

Flow cytometry {#s0075}
--------------

The transfected HeLa cells were collected by 0.5% trypsin digestion at 24 and 48 h post-transfection, respectively. The cells were washed with PBS 2 times, and fixed with 75% precooling ethanol. Approximately 1×10^6^ cells were washed and resuspended in 0.4 ml of precooling PBS two times. The cells were incubated with 40 mg/ml of propidium iodide (PI) (Sigma, St. Louis, MO) and 40 mg/ml of RNase (Sigma) at 37 °C for 30 min, and applied to cell cycle analysis with a flow cytometer FACSCalibur (BD Bioscience, San Jose, CA). The data were analyzed by Cell-Quest ModiFit software (BD Bioscience) and plotted by Sigmaplot 11 (Systat Software, Richmond, CA).
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